Bromodomain Inhibitors as Therapeutics for Herpesvirus-Related Disease: All BETs Are Off? (2020)
Attributed to:
Understanding human cytomegalovirus latency as a means to target the latent reservoir
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fcimb.2020.00329
PubMed Identifier: 32714883
Publication URI: http://europepmc.org/abstract/MED/32714883
Type: Journal Article/Review
Volume: 10
Parent Publication: Frontiers in cellular and infection microbiology
ISSN: 2235-2988